Addiction, Pain, and Public Health website
doctordeluca.com - war on doctors/pain crisis blog
 
 
 [Home] [Library]  [Slides]  [Search]  [Medline]  [Links]
 
[Statements of Purpose, Ownership, Sponsorship. Privacy,  Email Confidentiality, and Advertising Policies]

Treating Doctors as Drug Dealers - The DEA's War on Prescription Painkillers

 
Ronald T. Libby, professor at the University of North Florida; Cato Policy Analysis, #545; 2005-06-16; Posted: 2005-06-07; Modified: 2005-06-07
[Identifier= http://www.doctordeluca.com/Library/WOD/TreatingDocsAsDealers-Cato05.htm]
Source:  http://www.cato.org/pub_display.php?pub_id=3778
 
Related resources:  
Drug War Journalism and Advocacy archives  ;  WAR ON PAIN SUFFERERS Special Collections
 
See also:
WAR ON PAIN SUFFERERS #4 - The Dr. William Hurwitz Collection
 
War on Drugs, War on Doctors, and the Pain Crisis in America - DeLuca; 20004.
 
Dr. Feelscared - Maia Szalavitz; Reason; 2004
 
War on Doctors/Pain Crisis blog and RSS feed
 

[Full Text of this Article in Adobe PDF format]

Executive Summary
 
The medical field of treating chronic pain is still in its infancy. It was only in the late 1980s that leading physicians trained in treating the chronic pain of terminally ill cancer patients began to recommend that the "opioid therapy" (treatment involving narcotics related to opium) used on their patients also be used for patients suffering from nonterminal conditions. The new therapies proved successful, and prescription pain medications saw a huge leap in sales throughout the 1990s. But opioid therapy has always been controversial. The habit-forming nature of some prescription pain medications made many physicians, medical boards, and law enforcement officials wary of their use in treating acute pain in nonterminal patients. Consequently, many physicians and pain specialists have shied away from opioid treatment, causing millions of Americans to suffer from chronic pain even as therapies were available to treat it.

The problem was exacerbated when the media began reporting that the popular narcotic pain medication OxyContin was finding its way to the black market for illicit drugs, resulting in an outbreak of related crime, overdoses, and deaths. Though many of those reports proved to be exaggerated or unfounded, critics in Congress and the Department of Justice scolded the U.S. Drug Enforcement Administration for the alleged pervasiveness of OxyContin abuse.

The DEA responded with an aggressive plan to eradicate the illegal use or "diversion" of OxyContin. The plan uses familiar law enforcement methods from the War on Drugs, such as aggressive undercover investigation, asset forfeiture, and informers. The DEA’s painkiller campaign has cast a chill over the doctor-patient candor necessary for successful treatment. It has resulted in the pursuit and prosecution of well meaning doctors. It has also scared many doctors out of pain management altogether, and likely persuaded others not to enter it, thus worsening the already widespread problem of undertreated or untreated chronic pain.

[Full Text of this Article in Adobe PDF format]